TickerFacts.

Caris Life Sciences, Inc. (CAI): Share Repurchases

Annual figures by period end, from SEC filings.

$113.0K
Year ended 2025-12-31
$21.45M
Trailing 12 months to 2026-06-30
2023-12-31: $02024-12-31: $02025-12-31: $113.0K$113.0K
2023-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$113.0Kn/a2026-03-03, From 2025-01-01
2024-12-31$0n/a2026-03-03, From 2024-01-01
2023-12-31$0n/a2026-03-03, From 2023-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Caris Life Sciences, Inc. (CAI)2025-12-31$113.0Kn/a
Guardant Health, Inc. (GH)2025-12-31$45.01Mn/a
CareDx, Inc. (CDNA)2025-12-31$87.77Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31$10.88Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$0-100.0%
Quest Diagnostics Inc (DGX)2025-12-31$450.00M+198.0%
Labcorp Holdings Inc. (LH)2025-12-31$450.00M+79.9%

Compare CAI, GH, CDNA, FLGT side by side · Screen every company in Services-Medical Laboratories ↗